Abiopharma

New Form SCHEDULE 13G/A - Personalis, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003485 <b>Size:</b> 11 KB

New Form SCHEDULE 13G/A - CYBIN INC. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005201 <b>Size:</b> 11 KB

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: NOTIFICATION FOR DIRECTOR/CEO

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results

New Form SCHEDULE 13G/A - ENTRAVISION COMMUNICATIONS CORP <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000215 <b>Size:</b> 14 KB

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): NOTIFICATION FOR SUBSTANTIAL SHAREHOLDER - U.I.P. HOLDINGS LIMITED

New Form 20-F - Paranovus Entertainment Technology Ltd. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001929980-26-000454 <b>Size:</b> 8 MB

New Form SCHEDULE 13G/A - ANAPTYSBIO, INC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005200 <b>Size:</b> 10 KB

Mandatory Cash Dividend/ Distribution:

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): NOTIFICATION FOR SUBSTANTIAL SHAREHOLDER - K.I.P. INC

New Form SCHEDULE 13G/A - Alto Neuroscience, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005199 <b>Size:</b> 11 KB

New Form 424B5 - Outlook Therapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001104659-26-096504 <b>Size:</b> 742 KB

New Form SCHEDULE 13G/A - VAIL RESORTS INC <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000902664-26-003459 <b>Size:</b> 10 KB

New Form SCHEDULE 13G/A - DXC Technology Co <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000213 <b>Size:</b> 14 KB